Zobrazeno 1 - 10 of 99 pro vyhledávání: '"P.-D. Ghislain"'
1
Systemic treatment of children and adolescents with atopic dermatitis aged ≥2 years: a Delphi consensus project mapping expert opinion in Northern Europe
Autor: M. de Graaf, S.R. Janmohamed, M.L.A. Schuttelaar, T. Agner, J.H. Alfonso, S. De Schepper, M. Deleuran, K. Despontin, V. Elenius, P.‐D. Ghislain, L. Huilaja, E.K. Johansson, B.K. Kvenshagen, J.M. Mandelin, H. Olset, A. Svensson, A.M. van Tuyll van Serooskerken, J.P. Thyssen, C. Vestergaard
Publikováno v: Journal of the European Academy of Dermatology and Venereology : JEADV, Vol. 36, no. 11, p. 2153-2165 (2022)
Journal of the European Academy of Dermatology and Venereology, 36(11), 2153-2165. Wiley
de Graaf, M, Janmohamed, S R, Schuttelaar, M L A, Agner, T, Alfonso, J H, De Schepper, S, Deleuran, M, Despontin, K, Elenius, V, Ghislain, P D, Huilaja, L, Johansson, E K, Kvenshagen, B K, Mandelin, J M, Olset, H, Svensson, A, van Tuyll van Serooskerken, A M, Thyssen, J P & Vestergaard, C 2022, ' Systemic treatment of children and adolescents with atopic dermatitis aged ≥2 years : a Delphi consensus project mapping expert opinion in Northern Europe ', Journal of the European Academy of Dermatology and Venereology, vol. 36, no. 11, pp. 2153-2165 . https://doi.org/10.1111/jdv.18410
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY
Publisher Copyright: © 2022 The Authors. Journal of the European Academy of Dermatology and Venereology published by John Wiley & Sons Ltd on behalf of European Academy of Dermatology and Venereology. Background: Paediatric atopic dermatitis (AD) ca
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::52946adca1a7aeaf1012842fae32da83
https://doi.org/10.1111/jdv.18410
Zobrazit plný text záznamu
2
Secukinumab demonstrated sustained retention, effectiveness and safety in a real‐world setting in patients with moderate‐to‐severe plaque psoriasis: long‐term results from an interim analysis of the SERENA study
Autor: M, Augustin, P G, Sator, R, von Kiedrowski, C, Conrad, D, Rigopoulos, M, Romanelli, P-D, Ghislain, T, Torres, D, Ioannides, M, Aassi, B, Schulz, P, Jagiello
Publikováno v: Journal of the European Academy of Dermatology and Venereology. 36:1796-1804
Randomized controlled trials of secukinumab have shown sustained efficacy and a favourable safety profile in multiple manifestations of psoriatic disease.To assess the long-term, real-world retention, effectiveness and safety of secukinumab in routin
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7d1b9f56e08e29b6e107ee90e4d3b1b0
https://doi.org/10.1111/jdv.18329
Zobrazit plný text záznamu
4
Real-life effectiveness and short-term (16-week) tolerance of guselkumab for psoriasis: a Belgian retrospective multicentre study
Autor: F. Guiot, Rani Soenen, M. de la Brassinne, Jo Lambert, P.-D. Ghislain, H. Fierens, V. Del Marmol, F. Willaert, Farida Benhadou
Publikováno v: Journal of the European Academy of Dermatology and Venereology, Vol. 34, no. 12, p. e837-e839 (2020)
JEADV. Journal of the European Academy of Dermatology and Venereology
SCOPUS: le.j
info:eu-repo/semantics/published
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::da983f3e600aaa39b880af498c11cc41
https://pubmed.ncbi.nlm.nih.gov/32535976
Zobrazit plný text záznamu
5
Practical recommendations for systemic treatment in psoriasis in case of coexisting inflammatory, neurologic, infectious or malignant disorders (BETA-PSO: Belgian Evidence-based Treatment Advice in Psoriasis; part 2)
Autor: Siegfried Segaert, Reinhart Speeckaert, P.-D. Ghislain, Arjen Nikkels, Tom Hillary, Julien Lambert, J. Lambert, F. Willaert
Publikováno v: Journal of the European Academy of Dermatology and Venereology
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY
Journal of the European Academy of Dermatology and Venereology, Vol. 34, no. 9, p. 1914-1923 (2020)
BACKGROUND: Psoriasis patients carry an increased risk for associated comorbidities. Dermatologists have to be aware of the effects of systemic treatments not only on psoriasis but also on co-occurring diseases. In case of other coexisting inflammato
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::24a762dd311724cb08dcaa39b322aab2
https://pubmed.ncbi.nlm.nih.gov/32791572
Zobrazit plný text záznamu
6
Effectiveness and short-term (16-week) tolerance of guselkumab for psoriasis under real-life conditions: a retrospective multicenter study
Autor: C. Jacobzone, Gem Resopso, François Maccari, J. Parier, D Bouilly Auvray, A-C Fougerousse, Edouard Begon, C. Clément, Z. Reguiai, Valérie Pallure, Eric Esteve, P.-D. Ghislain, J-L Schmutz, G. Chaby
Publikováno v: Journal of the European Academy of Dermatology and Venereology, Vol. 34, no. 10, p. e644-e646 (2020)
Guselkumab (Tremfya , Janssen Biotech, Inc., Horsham, PA, USA) is an anti-IL-23 p19 antibody, recently marketed for the management of moderate to severe psoriasis in adults. To date, there are only limited post-marketing data available on its effecti
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::00ebd61082f236b21139b67410d0216d
https://hdl.handle.net/2078.1/229902
Zobrazit plný text záznamu
7
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
8
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
9
Efficacité et tolérance à court terme (16 semaines) du guselkumab pour du psoriasis en vraie vie : étude rétrospective multicentrique
Autor: Gem Resopso, C. Clément, G. Chaby, P.-D. Ghislain, Anne-Claire Fougerousse, J. Parier, Valérie Pallure, Z. Reguiai, Eric Esteve, J.-L. Schmutz, D. Bouilly-Auvray, Edouard Begon, François Maccari, C. Jacobzone
Publikováno v: Annales de Dermatologie et de Vénéréologie. 147:A326-A327
Introduction Le guselkumab (G) a recemment ete commercialise pour la prise en charge du psoriasis modere a severe de l’adulte. Les donnees d’efficacite et de tolerance post-commercialisation sont limitees a ce jour. Materiel et methodes Etude ret
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::5242dfe0e92053dcb3fa2ce55d41be77
https://doi.org/10.1016/j.annder.2020.09.499
Zobrazit plný text záznamu
10
Ixekizumab improves secondary lesional signs, pain and sexual health in patients with moderate-to-severe genital psoriasis
Autor: A. Potts Bleakman, Russel Burge, P.-D. Ghislain, Joseph F. Merola, Alan Brnabic, E. Riedl, J.N. Dauendorffer
Publikováno v: Journal of the European Academy of Dermatology and Venereology
Journal of the European Academy of Dermatology and Venereology, Vol. 34, no. 6, p. 1257-1262 (2020)
Background Epithelial surface disruption in genital psoriatic lesions may manifest as erosions, fissures and/or ulcers, causing pain and significantly impacting a patient's sexual health. Objective To evaluate the impact of erosions, fissures and/or
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6b55daa1db0ff093b63a3d07113b49ae
https://pubmed.ncbi.nlm.nih.gov/31919919
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje